Seeing Is Believing

Currently out of the existing stock ratings of Bruce Jackson, 213 are a BUY (91.81%), 19 are a HOLD (8.19%).
Analyst Bruce Jackson, carries an average stock price target met ratio of 45.52% that have a potential upside of 32.84% achieved within 206 days. Previously, Bruce Jackson worked at BENCHMARK.
Bruce Jackson’s has documented 412 price targets and ratings displayed on 34 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on NEO, NeoGenomics at 06-Oct-2026.
Analyst best performing recommendations are on GNLX (GENELUX).
The best stock recommendation documented was for BFRI (BIOFRONTERA) at 12/15/2021. The price target of $220 was fulfilled within 6 days with a profit of $81 (58.27%) receiving and performance score of 97.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jul-2021
$7.5
5 years 3 months 4 days ago
(22-Jul-2021)
2/2 (100%)
$2.76 (58.23%)
256
Hold Since 03-Dec-2020
$10
$9.54 (2073.91%)
$8
5 years 10 months 23 days ago
(03-Dec-2020)
0/3 (0%)
$2.49 (33.16%)
Hold Since 17-Jun-2020
$7
6 years 4 months 9 days ago
(17-Jun-2020)
2/2 (100%)
$-0.16 (-2.23%)
151
Buy Since 26-May-2020
$4
$3.54 (769.57%)
$21
6 years 4 months 9 days ago
(17-Jun-2020)
1/2 (50%)
$0.11 (2.83%)
15
Buy Since 04-Jan-2019
$9
6 years 10 months 10 days ago
(16-Dec-2019)
2/2 (100%)
$4.61 (105.01%)
309
Which stock is Bruce Jackson most bullish on?
Which stock is Bruce Jackson most reserved on?